AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH. |  |
|
 | CEOMr. Michael H. Carrel Chief Financial OfficerMs. Angela L. Wirick Chief Operating OfficerMr. Douglas J. Seith Chief Technical OfficerMr. Salvatore Privitera J.D. Chief Marketing & Strategy OfficerMr. Justin J. Noznesky |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Prange Karen | Director | May 20 '26 | Sale | 28.65 | 3,000 | 85,950 | 26,373 | May 22 08:57 AM | | Prange Karen | Director | May 20 '26 | Proposed Sale | 28.80 | 3,000 | 86,400 | | May 20 08:24 AM | | Doraiswamy Vinayak | Chief Scientific Officer | May 15 '26 | Sale | 28.13 | 5,000 | 140,650 | 91,875 | May 18 04:01 PM | | VINAYAK DORAISWAMY | Officer | May 15 '26 | Proposed Sale | 28.13 | 5,000 | 140,674 | | May 15 05:05 PM | | Doraiswamy Vinayak | Chief Scientific Officer | Mar 12 '26 | Sale | 29.83 | 5,000 | 149,150 | 96,875 | Mar 16 08:14 AM | | VINAYAK DORAISWAMY | Officer | Mar 12 '26 | Proposed Sale | 29.83 | 5,000 | 149,152 | | Mar 12 04:38 PM | | WHITE ROBERT S. | Director | Mar 10 '26 | Option Exercise | 14.99 | 10,000 | 149,900 | 122,174 | Mar 12 08:52 AM | | WEHRWEIN SVEN | Director | Nov 24 '25 | Option Exercise | 19.95 | 5,033 | 100,408 | 39,407 | Nov 26 04:43 PM | | WEHRWEIN SVEN | Director | Nov 25 '25 | Option Exercise | 19.95 | 4,967 | 99,092 | 39,341 | Nov 26 04:43 PM | | WEHRWEIN SVEN | Director | Nov 25 '25 | Sale | 38.00 | 4,967 | 188,746 | 34,374 | Nov 26 04:43 PM | | WEHRWEIN SVEN | Director | Nov 24 '25 | Sale | 37.32 | 5,033 | 187,832 | 34,374 | Nov 26 04:43 PM | | Noznesky Justin J | Chief Mktg & Strategy Officer | Nov 26 '25 | Sale | 37.29 | 5,166 | 192,640 | 78,798 | Nov 26 04:41 PM | | Noznesky Justin J | Officer | Nov 26 '25 | Proposed Sale | 37.29 | 5,166 | 192,642 | | Nov 26 11:48 AM | | SVEN WEHRWEIN | Director | Nov 25 '25 | Proposed Sale | 38.00 | 4,967 | 188,746 | | Nov 25 04:06 PM | | Yuen Maggie | Director | Nov 21 '25 | Sale | 35.72 | 3,000 | 107,160 | 11,371 | Nov 25 09:01 AM | | SVEN WEHRWEIN | Director | Nov 24 '25 | Proposed Sale | 37.32 | 5,033 | 187,854 | | Nov 24 05:41 PM | | MAGGIE YUEN | Director | Nov 21 '25 | Proposed Sale | 35.72 | 3,000 | 107,158 | | Nov 21 05:53 PM | | Noznesky Justin J | Chief Mktg & Strategy Officer | Sep 12 '25 | Sale | 36.30 | 3,000 | 108,900 | 83,964 | Sep 16 08:45 AM | | Noznesky Justin J | Officer | Sep 12 '25 | Proposed Sale | 36.30 | 3,000 | 108,891 | | Sep 12 02:17 PM | | WEHRWEIN SVEN | Director | Aug 22 '25 | Option Exercise | 19.95 | 5,000 | 99,750 | 39,374 | Aug 26 08:27 AM | | WEHRWEIN SVEN | Director | Aug 22 '25 | Sale | 37.00 | 5,000 | 185,000 | 34,374 | Aug 26 08:27 AM | | SVEN WEHRWEIN | Director | Aug 22 '25 | Proposed Sale | 37.00 | 5,000 | 185,000 | | Aug 22 04:01 PM | | WEHRWEIN SVEN | Director | Aug 19 '25 | Option Exercise | 19.95 | 5,000 | 99,750 | 39,374 | Aug 21 09:04 AM | | WEHRWEIN SVEN | Director | Aug 19 '25 | Sale | 36.00 | 5,000 | 180,000 | 34,374 | Aug 21 09:04 AM | | SVEN WEHRWEIN | Director | Aug 19 '25 | Proposed Sale | 36.00 | 5,000 | 180,000 | | Aug 19 04:12 PM | | GROVES REGINA E | Director | Aug 06 '25 | Sale | 36.82 | 2,452 | 90,283 | 33,715 | Aug 08 09:12 AM | | Doraiswamy Vinayak | Chief Scientific Officer | Aug 05 '25 | Sale | 36.58 | 2,500 | 91,450 | 71,872 | Aug 07 08:45 AM | | GROVES REGINA E | Director | Aug 06 '25 | Proposed Sale | 36.83 | 2,452 | 90,307 | | Aug 06 10:38 AM | | VINAYAK DORAISWAMY | Officer | Aug 05 '25 | Proposed Sale | 36.58 | 2,500 | 91,442 | | Aug 05 04:08 PM |
|